Quince Therapeutics, Inc.
SEC Filing List
QNCX CIK: 0001662774
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 8-K | Current report filing | Quince Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/09/2026 | |
| NT 10-K | Notice under Rule 12b25 of inability to ... | Quince Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/01/2026 | |
| 8-K | Current report filing | Quince Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 03/30/2026 | |
| 8-K | Current report filing | Quince Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 03/20/2026 | |
| SCHEDULE 13G | 03/05/2026 | ||||
| 8-K | Current report filing | Quince Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 02/12/2026 | |
| 8-K | Current report filing | Quince Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 02/02/2026 | |
| 8-K | Current report filing | Quince Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 01/29/2026 | |
| 4 | Statement of changes in beneficial owner... | Hannah Brendan | DORSEY & WHITNEY LLP /FA/ | 01/23/2026 | |
| 4 | Statement of changes in beneficial owner... | Thye Dirk | DORSEY & WHITNEY LLP /FA/ | 01/23/2026 | |
| No record found. | |||||
| Load More | |||||
